T. Rowe Price Associates’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $130M | Buy |
|
|||||
|
2025
Q2 | $61.7M | Sell |
|
|||||
|
2025
Q1 | $80.1M | Sell |
|
|||||
|
2024
Q4 | $123M | Sell |
|
|||||
|
2024
Q3 | $167M | Buy |
|
|||||
|
2024
Q2 | $128M | Sell |
|
|||||
|
2024
Q1 | $205M | Sell |
|
|||||
|
2023
Q4 | $271M | Buy |
|
|||||
|
2023
Q3 | $29.8M | Sell |
|
|||||
|
2023
Q2 | $35.4M | Sell |
|
|||||
|
2023
Q1 | $41.2M | Buy |
|
|||||
|
2022
Q4 | $50.8M | Buy |
|
|||||
|
2022
Q3 | $53M | Buy |
|
|||||
|
2022
Q2 | $19.6M | Buy |
|
|||||
|
2022
Q1 | $17M | Buy |
|
|||||
|
2021
Q4 | $6.81M | Buy |
|
|||||
|
2021
Q3 | $1.05M | Buy |
|
|||||
|
2021
Q2 | $563K | Buy |
|
|||||
|
2021
Q1 | $632K | Buy |
|
|||||
|
2020
Q4 | $489K | Sell |
|
|||||
|
2020
Q3 | $14.3M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $3.48M | Buy |
|
|||||
|
2017
Q3 | $6.17M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $10.9M | Sell |
|
|||||
|
2013
Q2 | $17.1M | Buy |
|